Growth Metrics

ADC Therapeutics (ADCT) Amortizatization of Intangibles (2019 - 2026)

ADC Therapeutics has reported Amortizatization of Intangibles over the past 8 years, most recently at $6.8 million for Q1 2026.

  • Quarterly results put Amortizatization of Intangibles at $6.8 million for Q1 2026, down 3.25% from a year ago — trailing twelve months through Mar 2026 was $941000.0 (down 96.69% YoY), and the annual figure for FY2025 was $1.2 million, down 95.85%.
  • Amortizatization of Intangibles reached $6.8 million in Q1 2026 per ADCT's latest filing, up from $113000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $26.7 million in Q4 2024 and bottomed at -$12.9 million in Q3 2025.
  • Median Amortizatization of Intangibles over the past 5 years was $861000.0 (2023), compared with a mean of $4.0 million.
  • The largest annual shift saw Amortizatization of Intangibles surged 3810934.48% in 2023 before it tumbled 4331.88% in 2024.
  • Over 5 years, Amortizatization of Intangibles stood at $12.2 million in 2022, then tumbled by 41.35% to $7.2 million in 2023, then skyrocketed by 273.59% to $26.7 million in 2024, then plummeted by 99.58% to $113000.0 in 2025, then skyrocketed by 5952.21% to $6.8 million in 2026.
  • Business Quant data shows Amortizatization of Intangibles for ADCT at $6.8 million in Q1 2026, $113000.0 in Q4 2025, and -$12.9 million in Q3 2025.